MARAVAI LIFE SCIENCES HOLDINGS 2 LLC 13D and 13G filings for Maravai LifeSciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:48 pm Sale | 2024-09-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MARAVAI LIFE SCIENCES HOLDINGS 2 LLC | 130,834,085 51.810% | -9,940,974 (-7.06%) | Filing |
| 2024-02-08 4:45 pm Sale | 2023-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MARAVAI LIFE SCIENCES HOLDINGS 2 LLC | 140,775,059 56.020% | -4,575,170 (-3.15%) | Filing |
| 2022-02-11 4:16 pm Sale | 2021-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MARAVAI LIFE SCIENCES HOLDINGS 2 LLC | 145,350,229 56.970% | -43,270,415 (-22.94%) | Filing |
| 2021-02-11 4:00 pm Purchase | 2020-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MARAVAI LIFE SCIENCES HOLDINGS 2 LLC | 188,620,644 73.200% | 188,620,644 (New Position) | Filing |